Key Takeaways
- The U.S. government under the Trump Administration is distributing $2 billion in quantum computing grants across nine companies while acquiring equity positions in each.
- Despite being the most prominent pure-play quantum computing company publicly traded, IonQ was excluded from receiving any funding.
- Competitors including D-Wave Quantum (QBTS), Rigetti Computing (RGTI), and Infleqtion (INFQ) secured $100 million each, while IBM landed $1 billion.
- Shares of IonQ climbed approximately 9.5% Thursday morning, even as Wall Street forecasts continued losses extending multiple years ahead.
- According to MarketBeat data, analyst consensus on IonQ remains at “Moderate Buy” with a mean price target of $68.63.
During its most recent quarterly report, IonQ delivered revenue of $64.67 million — representing an impressive 754.7% increase compared to the prior year — yet the firm fell short of earnings projections, recording a per-share loss of $0.34 versus analyst expectations of a $0.26 loss.
Opening Thursday’s session around $52.53, IONQ shares advanced approximately 9.5% despite the company’s omission from a substantial government funding initiative. This counterintuitive price action exemplifies why quantum computing equities remain both captivating for observers and challenging for financial modeling.
According to an exclusive report from The Wall Street Journal, the Trump Administration’s initiative will distribute $2 billion among nine quantum computing enterprises. The federal government will simultaneously acquire ownership stakes in every recipient, creating aligned financial incentives moving forward.
IBM dominates the allocation with $1 billion of the total funding pool. Globalfoundries is slated to receive $375 million. D-Wave, Rigetti, and Infleqtion each secured $100 million allocations. The balance flows to several private sector entities, including a firm partially backed by 1789 Capital, which counts Donald Trump Jr. among its principals.
IonQ received nothing from this distribution.
Implications of Grant Awards for IonQ’s Competition
The federal government’s equity participation extends beyond mere capital infusion for grant recipients — it establishes direct governmental stake in these companies’ success. This creates a strategic market advantage that IonQ’s rivals now possess.
D-Wave (QBTS) soared more than 24%, Rigetti (RGTI) rallied nearly 25%, and Infleqtion (INFQ) advanced over 30% following the announcement. IBM shares increased close to 8%.
The puzzling element for market participants is understanding IonQ’s upward movement. A plausible explanation: the government’s substantial sector investment legitimizes the broader quantum computing industry, creating positive sentiment across all participants — including those excluded from direct funding.
Analyst Perspective on IonQ
Currently, ten analysts maintain Buy recommendations on IONQ. Six analysts rate it Hold, while one has assigned a Sell rating. The overall consensus registers as “Moderate Buy” with a collective price target of $68.63.
However, Morgan Stanley maintains a more conservative $48.50 price objective, and DA Davidson reduced its target from $55 down to $35 with a neutral stance in February. Skepticism persists among certain analysts.
The company commands a market capitalization near $19.6 billion, exhibits a beta coefficient of 3.05, and trades within a 52-week band of $25.89 to $84.64. The 50-day moving average registers at $39.31.
Institutional ownership has been expanding. DNB Asset Management increased its IonQ position by more than 1,099% during Q4, elevating its holdings to 55,230 shares valued at approximately $2.48 million. Multiple additional institutional investors have established positions.
Regarding insider transactions, Director William Teuber acquired 3,000 shares at $38.38 per share in late February. Company insiders collectively divested 12,354 shares worth $504,428 throughout the previous quarter.
Sell-side analysts project a full fiscal year EPS of -$1.99, indicating profitability remains a distant prospect.


